.AstraZeneca has actually shared an early examine the efficiency of its own internal antibody-drug c...
.After announcing a phase 3 launch based upon good midstage end results, iTeos and also GSK are actu...
.The FDA needs to be extra open as well as collective to unleash a rise in approvals of rare ailment...
.It is actually an unusually active Friday for biotech IPOs, with Zenas BioPharma, MBX as well as Bi...
.Atea Pharmaceuticals' antiviral has actually neglected another COVID-19 test, however the biotech s...
.Neurocrine Biosciences' mental illness program pivot has failed. The biotech was unable to reproduc...
.Sanofi has actually brought in an overdue access to the radioligand event, paying out one hundred m...
.After F2G's 1st effort to receive a brand-new class of antifungal to market was actually hindered b...
.Moderna has vowed to cut R&D spending through $1.1 billion through 2027. The decision to retract...
.Just four months after Sanofi wager $80 million in upfront cash money on Fulcrum Rehabs' losmapimod...